Phi Med Europe
Curated by SignalDeveloper of a device to detect an early sensitive nerves fibers dysfunction in neuropathies
Overview
Developer of a device to detect an early sensitive nerves fibers dysfunction in neuropathies. The company has developed, NerveCheck Master, a Quantitative Sensory Testing device that allows early diagnosis of sensory nerve fibres alterations with a focus on Diabetic Neuropathy. It performs 4 different tests Vibration, Cold, Warm and Heat Pain test. It can also be used for Neurological diseases, Leprosy, HIV-AIDS, Cancer Patients under Chemotherapy, Traumatic Nerves Lesions, and Collagen Diseases.
Key facts
- Founded
- 2011
- Headquarters
- Barcelona, Spain
- Stage
- Sign up to view
- Industry
- Life Sciences Technology
Business model
- 1 product or service
- Sign up to view